JP2022540432A5 - - Google Patents

Info

Publication number
JP2022540432A5
JP2022540432A5 JP2022500795A JP2022500795A JP2022540432A5 JP 2022540432 A5 JP2022540432 A5 JP 2022540432A5 JP 2022500795 A JP2022500795 A JP 2022500795A JP 2022500795 A JP2022500795 A JP 2022500795A JP 2022540432 A5 JP2022540432 A5 JP 2022540432A5
Authority
JP
Japan
Prior art keywords
alkyl
pentyl
dioxyno
chromen
benzo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2022500795A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022540432A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2020/050966 external-priority patent/WO2021007660A1/en
Publication of JP2022540432A publication Critical patent/JP2022540432A/ja
Publication of JP2022540432A5 publication Critical patent/JP2022540432A5/ja
Ceased legal-status Critical Current

Links

JP2022500795A 2019-07-12 2020-07-10 カンナビノイド誘導体 Ceased JP2022540432A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962873686P 2019-07-12 2019-07-12
US62/873,686 2019-07-12
PCT/CA2020/050966 WO2021007660A1 (en) 2019-07-12 2020-07-10 Cannabinoid derivatives

Publications (2)

Publication Number Publication Date
JP2022540432A JP2022540432A (ja) 2022-09-15
JP2022540432A5 true JP2022540432A5 (enExample) 2023-07-13

Family

ID=74209617

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022500795A Ceased JP2022540432A (ja) 2019-07-12 2020-07-10 カンナビノイド誘導体

Country Status (5)

Country Link
US (1) US20220259221A1 (enExample)
EP (1) EP3997095B1 (enExample)
JP (1) JP2022540432A (enExample)
ES (1) ES3014632T3 (enExample)
WO (1) WO2021007660A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021007663A1 (en) 2019-07-12 2021-01-21 Canopy Growth Corporation Cannabinoid derivatives
JP2022540586A (ja) 2019-07-12 2022-09-16 キャノピー グロウス コーポレイション カンナビノイド誘導体
US12252503B2 (en) 2019-07-12 2025-03-18 Canopy Growth Corporation Cannabinoid derivatives
JP2022551066A (ja) 2019-10-02 2022-12-07 キャノピー グロウス コーポレイション カンナビノイド誘導体
WO2021102567A1 (en) 2019-11-26 2021-06-03 Canopy Growth Corporation Cannabigerol derivatives and use thereof as cannabinoid receptor modulators
US12240813B2 (en) 2020-05-19 2025-03-04 Cybin Irl Limited Deuterated tryptamine derivatives and methods of use
EP4222260A4 (en) * 2020-10-02 2025-01-15 Bessor Pharma, LLC PROCESS FOR THE PRODUCTION OF CANNABINOL, CANNABINOLIC ACID, CANNABIVARIN, CANNABIVARIN ACID AND RELATED CANNABINOIDS
EP4471038A1 (en) 2023-05-30 2024-12-04 Tresco Holding GmbH Process for the synthesis of tetrahydrocannabinolic acid dimethylsiloxane, and tetrahydrocannabinolic acid dimethylsiloxane

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070179135A1 (en) * 2006-01-05 2007-08-02 Travis Craig R Cannabinoid derivatives
AU3910700A (en) * 1999-03-22 2000-10-09 Immugen Pharmaceuticals, Inc. Treatment of immune diseases
US20050009903A1 (en) 2003-06-10 2005-01-13 Martin Billy R. CB2-selective cannabinoid analogues
WO2014039042A1 (en) * 2012-09-06 2014-03-13 Northeastern University Novel cannabinergic compounds and uses thereof
WO2014134127A1 (en) 2013-02-26 2014-09-04 Northeastern University Cannabinergic nitrate esters and related analogs
WO2019234728A1 (en) * 2018-06-04 2019-12-12 Al&Am Pharmachem Ltd. Cannabinolic acid derivatives and uses thereof
JP2021535203A (ja) * 2018-08-20 2021-12-16 ベッソール ファルマ、エルエルシー 既知および新規カンナビノイドの適用

Similar Documents

Publication Publication Date Title
JP2022540432A5 (enExample)
JP2022539400A5 (enExample)
JP2022539401A5 (enExample)
JP2022540434A5 (enExample)
JP2022540586A5 (enExample)
JP2023503331A5 (enExample)
JP2023503601A5 (enExample)
JP2022540585A5 (enExample)
JP2022540433A5 (enExample)
JP2022551066A5 (enExample)
IL287159B2 (en) Small molecules agonists for FXR (farnesoid X receptor) and method for their preparation and use
JP6605020B2 (ja) Nr2b受容体阻害剤としてのトリアゾール
JP2012522793A5 (enExample)
AR074184A1 (es) Compuestos de 7-azaspiro[3.5]nonano-7-carboxamida, composiciones farmaceuticas que los comprenden y su uso en la fabricacion de medicamentos para el tratamiento de afecciones mediadas por la inhibicion de faah
JP2009523165A5 (enExample)
JP2010520264A5 (enExample)
JP2011510068A5 (enExample)
JP2023058571A (ja) 軟膏剤
JP2017525700A (ja) ピラゾール類
JP2010513334A (ja) Pde4阻害剤として有用な置換アセトフェノン
JP2017526614A5 (enExample)
WO2009118473A2 (fr) Composés dérivés d'azétidines, leur préparation et leur application en thérapeutique
JP2024508545A5 (enExample)
JP2019512515A (ja) 去勢抵抗性前立腺がんの処置のためのアンドロゲン受容体の核移行の低分子阻害剤
CN105189492A (zh) 麦角灵衍生物作为多巴胺受体调节剂